Research Article
Detection of Biofilm Production and Antibiotic Susceptibility Pattern among Clinically Isolated Staphylococcus aureus
Table 3
Antibiotic susceptibility pattern of bacterial isolates.
| | Antibiotics | MSSA (N = 49) | MRSA (N = 54) | Total (N = 103) | | Sensitive | Resistant | Sensitive | Resistant | Sensitive | Resistant | | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) |
| | Ampicillin (AMP) | 15 (30.7) | 34 (69.3) | — | — | 15 (30.7) | 34 (69.3) | | Cefoxitin (CX) | 49 (100) | 0 (0) | 0 (0) | 54 (100) | 49 (47.5) | 54 (52.4) | | Ceftazidime (CAZ) | 21 (42.8) | 28 (57.2) | 3 (5.6) | 51 (94.4) | 24 (23.3) | 79 (76.7) | | Ampicillin-clavulanate (AMPC) | 24 (49) | 25 (51) | 6 (11) | 48 (89) | 30 (18) | 73 (71) | | Gentamicin (GEN) | 34 (69.3) | 15 (30.7) | 24 (44.4) | 30 (55.6) | 58 (56.3) | 45 (43.7) | | Amikacin (AK) | 49 (100) | 0 (0) | 52 (96.3) | 2 (3.7) | 101 (98) | 2 (2) | | Cotrimoxazole (COT) | 28 (57.2) | 21 (42.8) | 14 (19) | 40 (74) | 42 (40.8) | 61 (59.2) | | Ofloxacin (OF) | 26 (53) | 23 (47) | 12 (22.2) | 42 (77.8) | 38 (37) | 65 (63) | | Levofloxacin (LE) | 30 (61.3) | 19 (38.7) | 16 (29.7) | 38 (70.3) | 46 (44.7) | 57 (55.3) | | Clindamycin (CD) | 39 (79.6) | 10 (20.4) | 44 (81.5) | 10 (18.5) | 83 (80.6) | 20 (19.4) | | Erythromycin (E) | 26 (53) | 23 (47) | 19 (35.2) | 35 (64.8) | 45 (43.7) | 58 (56.3) | | Linezolid (LZ) | 49 (100) | 0 (0) | 53 (98.2) | 1 (1.8) | 102 (99) | 1 (1) | | Vancomycin (VA) | 40 (81.6) | 9 (18.4) | 38 (70.3) | 16 (29.7) | 78 (75.7) | 25 (24.3) |
|
|
